Novel exendin agonist formulations and methods of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/22 (2006.01) A61K 9/08 (2006.01) A61K 9/19 (2006.01) A61K 38/00 (2006.01) A61K 38/17 (2006.01) A61K 38/26 (2006.01) A61K 47/02 (2006.01) A61K 47/10 (2006.01) A61K 47/12 (2006.01) A61K 47/18 (2006.01) A61K 47/26 (2006.01) A61K 47/34 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 5/50 (2006.01) C07K 14/575 (2006.01)

Patent

CA 2356706

Novel exendin and exendin agonist compound formulations and dosages and methods of administration thereof are provided. These compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.

L'invention concerne de nouvelles formulations de composés exendine et agonistes de l'exendine ainsi que des posologies et des modes d'administration de ces formulations. Ces compositions et ces modes d'administration sont utiles pour le traitement du diabète et des pathologies améliorées par une diminution du glucose dans le plasma ou un retard et/ou un ralentissement de la vidange gastrique ou une inhibition de l'absorption d'aliments.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel exendin agonist formulations and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel exendin agonist formulations and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel exendin agonist formulations and methods of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1771647

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.